ArticleKidney international reports2020
Preoperative Comorbidities and Outcomes of Medically Complex Living Kidney Donors.
Article in Kidney international reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 18 citations in OpenAlex.
- Long-Term Outcomes Across Age and Risk Profiles in a Caucasian Living Kidney Donor Cohort.Transplant international : official journal of the European Society for Organ Transplantation · 2026Article
- Association of renal volumetry and histological features with marginal donors: risks for donors and recipients in living donor kidney transplantation.Clinical and experimental nephrology · 2025Article
- Risk factors for cancer and the importance of screening in adult recipients of living-donor kidney transplant.Frontiers in immunology · 2025Article
- Outcomes in LD70s Redefining the Limits of Kidney Donation: Insights From Living Donors Aged 70 Years and Older.Kidney international reports · 2024Article
- Impact of Age 70 years or Older on Donors for Living-Donor Kidney Transplantation.Kidney international reports · 2024Article
- Living Donors' Age Modifies the Impact of Pre-Donation Estimated Glomerular Filtration Rate on Graft Survival.Journal of clinical medicine · 2023Article
- Prediction tool for renal adaptation after living kidney donation using interpretable machine learning.Frontiers in medicine · 2023Article
- Prediction models for the recipients' ideal perioperative estimated glomerular filtration rates for predicting graft survival after adult living-donor kidney transplantation.Frontiers in medicine · 2023Article
- Is a Patient with Paget's Disease of Bone Suitable for Living Kidney Donation?-Decision-Making in Lack of Clinical Evidence.Journal of clinical medicine · 2022Review
- Article
- Adult Living-Donor Kidney Transplantation, Donor Age, and Donor-Recipient Age.Kidney international reports · 2021Article
- The importance of kidney volume as a marker in the assessment of living-donor kidney transplantation in Japan.Clinical and experimental nephrology · 2021Observational
- Medically Complex Living Kidney Donors: Where Are We Now?Kidney international reports · 2020Article
Corrections and comments
- Commented on by
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionRecent reports have described an increased risk of renal disease in living kidney donors compared with the general population. However, these reports do not detail the outcomes of medically complex living donors (MCLDs) with preoperative comorbidities (PCs), such as hypertension, dyslipidemia, glucose intolerance, and obesity. Analysis of living donors with end-stage renal disease (ESRD) has shown that these PCs may contribute significantly to the development of ESRD. We aimed to evaluate the effect of PCs on postoperative renal function and mortality in MCLDs.
methodsBetween January 2008 and December 2016, 807 living-donor kidney transplants were performed in our unit. Of these, 802 donors completed postoperative follow-up of >5 months. Donors were stratified into 4 groups based on the number of PCs present: healthy living donors (HLDs) with no PCs (
resultsInterstitial fibrosis, tubular atrophy, glomerulosclerosis, and arteriolosclerosis were more frequent in MCLDs (PC 3) than in HLDs. No significant differences were identified between HLDs and MCLDs in terms of postoperative eGFR and short-term mortality. Overt proteinuria and ESRD were not observed.
conclusionsAppropriate postdonation management of MCLDs with PCs may result in similar outcomes as for HLDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.